OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies
Nader Akbari Dilmaghani, Ava Safaroghli‐Azar, Atieh Pourbagheri‐Sigaroodi, et al.
IUBMB Life (2021) Vol. 73, Iss. 4, pp. 618-642
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy
Ava Safaroghli‐Azar, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175827-175827
Closed Access | Times Cited: 25

The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances
Ayda Baghery Saghchy Khorasani, Nasim Hafezi, Mohammad‐Javad Sanaei, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 11

Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma
Hailong Li, Nian-Hua Deng, HE Xiu-sheng, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 29

Targeting mTOR for Anti-Aging and Anti-Cancer Therapy
Wencheng Fu, Geng Wu
Molecules (2023) Vol. 28, Iss. 7, pp. 3157-3157
Open Access | Times Cited: 17

The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer
Ealia Khosh Kish, Muhammad Choudhry, Yaser Gamallat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4772-4772
Open Access | Times Cited: 28

Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials
Zeinab Davoodi‐Moghaddam, Farideh Jafari‐Raddani, Mahda Delshad, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 15293-15310
Closed Access | Times Cited: 15

m6A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2
Chong Zhao, Fang Zhang, Yang Tian, et al.
Anti-Cancer Drugs (2024)
Closed Access | Times Cited: 6

Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
Shutao Zheng, Shuo He, Yan Liang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6

Curcumin nanoemulsions inhibit oral squamous cell carcinoma cell proliferation by PI3K/Akt/mTOR suppression and miR‐199a upregulation: A preliminary study
Wei Liu, Jian Wang, Chenping Zhang, et al.
Oral Diseases (2022) Vol. 29, Iss. 8, pp. 3183-3192
Closed Access | Times Cited: 19

Phytochemicals and their Nanoformulations for Overcoming Drug Resistance in Head and Neck Squamous Cell Carcinoma
Zhai Pingping, Nan Chen, Yong Tang
Pharmaceutical Research (2025)
Closed Access

Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy
Junjun Li, Yazhou Xiao, Huayue Yu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10

Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches
Gursimran Singh, Rohit Rohit, Pankaj Kumar, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
Haibo Zhang, Junkoo Yi, Hai Huang, et al.
Journal of Ginseng Research (2021) Vol. 46, Iss. 3, pp. 396-407
Open Access | Times Cited: 18

AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
Abdulmelik Aytatli, Neslisah Barlak, Fatma Şanli, et al.
Cellular Oncology (2021) Vol. 45, Iss. 1, pp. 41-56
Closed Access | Times Cited: 17

PSF toolkit: an R package for pathway curation and topology-aware analysis
Siras Hakobyan, Ani Stepanyan, Lilit Nersisyan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4

Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.
Mehdi Karimi‐Shahri, Hossein Javid, Alireza Sharbaf Mashhad, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 24, Iss. 10, pp. 1307-1323
Closed Access | Times Cited: 9

Cold Atmospheric Plasma Jet Irradiation Decreases the Survival and the Expression of Oncogenic miRNAs of Oral Carcinoma Cells
Yun‐Chien Cheng, Kuo‐Wei Chang, Jian-Hua Pan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16662-16662
Open Access | Times Cited: 3

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
Wei Ma, Yiqun Liao, Ziwen Gao, et al.
Clinical Medicine Insights Oncology (2022) Vol. 16
Open Access | Times Cited: 5

Changes in protein phosphorylation by insulin administration in the central nervous system of the gastropod mollusk <i>Lymnaea stagnalis</i>
Junko Nakai, Kengo Namiki, Yuki Totani, et al.
Biophysics and Physicobiology (2023) Vol. 20, Iss. 4, pp. n/a-n/a
Open Access | Times Cited: 1

Targeted small molecule therapy and inhibitors for lymphoma
Zhonghui Wang, Xiang Zheng, Guo‐Wu Rao, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 14, pp. 1465-1484
Closed Access

Page 1 - Next Page

Scroll to top